Thrombolytic Therapy: Current Status

Joseph C. Fratantoni, Paul Ness, Toby L. Simon

Research output: Contribution to journalReview articlepeer-review

Abstract

ALTHOUGH many details of the process of thrombogenesis are unclear, it is generally thought that it involves both platelet activity (adhesion and aggregation) and fibrin formation.1,2 Both processes appear to be active in arterial and venous thrombogenesis, although their relative importance is not certain. In any event, physiologic fibrinolysis is theoretically important in the resolution of both arterial and venous thrombi, and agents which enhance this process may function as thrombolytic agents. Experimental studies dealing with this hypothesis have been extensive and are generally reviewed elsewhere.3,4 More recently, a number of clinical trials have been conducted to evaluate thrombolytic therapy.

Original languageEnglish (US)
Pages (from-to)1073-1078
Number of pages6
JournalNew England Journal of Medicine
Volume293
Issue number21
DOIs
StatePublished - Nov 20 1975
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Thrombolytic Therapy: Current Status'. Together they form a unique fingerprint.

Cite this